期刊文献+

新加良附方对移植性人胃癌细胞F/FL表达的影响 被引量:4

The effects of Xinjialiangfu formula on F/FL expression of transplanted human gastric cancer cell ( BGC - 823 )
下载PDF
导出
摘要 目的观察新加良附方对移植性人胃癌细胞(BGC-823)F/FL的表达影响。方法建立移植性人胃癌动物模型,并将动物模型随机分为胃癌模型对照组、西药5-FU对照组及新加良附方高、中、低剂量组,共5组。新加良附方大、中、小剂量组给药量分别为10g/kg、5g/kg和2.5g/kg;5-FU组给药剂量为17mg/kg;模型组给予等量无菌生理盐水。连续给药、给水15d处死模型小鼠分离肿瘤,瘤块称重,石蜡包埋,并将肿瘤组织切片,免疫组化法检测F/FL表达。结果新加良附方高剂量组能上调肿瘤组织F蛋白表达,下调FL蛋白表达,与模型对照组比较,有统计学意义(P〈0.05);新加良附方中剂量组能下调FL蛋白表达,与模型组比较,有统计学意义(P〈0.05)。结论新加良附方能通过启动F/FL介导的受体依赖型细胞凋亡途径,上调肿瘤组织F蛋白表达,下调FL蛋白表达而诱导胃癌细胞发生凋亡。 Objective To observe the effects of Xinjialiangfu formula (XJLFF) on F/FL expression of transplanted human gastric cancer cell ( BGC - 823 ). Methods Animal models with human gastric cancer xenografts were established and randomly divided into 5 groups ; namely model control group, 5 - FU group, XJLFF high - dose group, XJLFF medium - dose group and XJLFF low - dose group. XJLFF groups of high, medium and low dosage were administered XJLFF at the amount of 10 g/kg, 5 g/kg and 2.5 g/kg respectively; while 5 - FU group was administered 5 - FU at a dose of 17 mg/kg, and the model control group was given equivalent sterile normal saline. All mice were sacrificed after 15 days of continuous drug and water delivery. The tumor bilks were separated, weighed, embedded in paraffin, dissected into slices, and F/FL expression was detected by immunohistochemical method. Results F protein expression in tumor tissue of XJLFF high - dose group was up - regulated, while FL protein expression was down - regulated, and there were statistically significant difference compared with model control group ( P 〈 0. 05). In XJLFF medium - dose group, FL protein expression was down - regulated, and it was also significantly different from that in model control group ( P 〈 0. 05 ). Conclusion The X.ILFF can up - regulate F protein expression and down - regulate FL expression in tumor tissue by starting F/FL - mediated receptor - dependent apoptosis pathway, thereby inducing apoptosis in gastric cancer cells. This finding indicates that an in - depth research on the anti - tumor effect of XJLFF is in need and worthwhile.
出处 《中国医学创新》 CAS 2010年第5期28-30,共3页 Medical Innovation of China
基金 基金项目:高等学校博士点基金(新教师基金)资助(编号:200800261007)
关键词 新加良附方 移植性人胃癌细胞 F/FL表达 Xinjialiangfu Formula Transplanted human gastric cancer cell (BGC -823 ) F/FL expression
  • 相关文献

参考文献4

二级参考文献37

共引文献18

同被引文献35

  • 1季加孚,李子禹.大肠癌的新辅助治疗[J].临床外科杂志,2005,13(11):682-684. 被引量:5
  • 2庄严,董青,陈信义,孙颖立,陈金龙.新加良附颗粒含药血清体外诱导人胃癌细胞凋亡研究[J].中国实验方剂学杂志,2007,13(8):32-35. 被引量:15
  • 3Folkman J. Tumor angiogenesis : Therapeutic implication [J]. N Engl JMed,1971,285(21 ) :1182 - 1186.
  • 4Ahn H, Lee HJ, Yoo MW, et al. Changes in clinicopathologieal features and survival after gastrectomy for gastric cancer over a 20-year period [J]. Sr J surg,2011,98(2) :255 -260.
  • 5Jeong O, Park YK. Cinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients [J]. J Gastric cancer, 2011,11 (2) :69 -77.
  • 6季加孚.我国胃癌防治30年回顾[J].中国肿瘤临床,2013,40(22):1346-1351.
  • 7Wagner AD, Moehler M. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era [J]. Curt Opin Oncol 2009,21 (4) :381 - 385.
  • 8Bang Y, Chung H, Xu J, et al. Pathological features of advanced gastric cancer(GC) :Relationship to human epidermal growth factor receptor 2 (HER2) pesitivity in the global screening programme of the ToGA trial [ abstract]. J Clin Oncol 2009,27 ( 15 ) :4556.
  • 9雒琳,马成杰,陈信义.新加良附方影响小鼠肝癌组织VEGF与MVD表达的研究[J].北京中医药,2008,27(5):378-380. 被引量:9
  • 10王婧,田劭丹,陈信义.中医药治疗中晚期胃癌进展[J].世界中西医结合杂志,2009,4(8):596-600. 被引量:26

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部